Garry Arthur Neil - Jun 9, 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
CEO and Chairman of the Board, Director
Signature
/s/ Christopher Sullivan, by Power of Attorney
Stock symbol
AVTX
Transactions as of
Jun 9, 2023
Transactions value $
$13,680
Form type
4
Date filed
6/13/2023, 04:39 PM
Previous filing
May 22, 2023
Next filing
Jun 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $13.7K +4K +43.38% $3.42* 13.2K Jun 9, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.